NASDAQ:GRCE | Profit Breakdown | Grace Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$15.92M-$15.79M-$15.79M
2026-03-31-$3.01M-$2.88M-$1.18M
2025-12-31-$2.45M-$2.32M-$2.32M
2025-09-30-$2.53M-$938,000.00-$938,000.00
2025-06-30-$3.09M-$3.36M-$3.36M
2025-03-31-$3.18M-$382,000.00$636,000.00
2024-12-31-$3.7M-$4.76M-$4.16M
2024-09-30-$4.83M-$4.28M-$3.43M
2024-06-30-$4.96M-$3.34M-$2.62M
2024-03-31-$3.26M-$4.06M-$3.17M
2023-12-31-$3.04M-$2.6M-$2.39M
2023-09-30-$2.09M-$3.72M-$3.27M
2023-06-30-$4.45M-$4.31M-$4.02M
2023-03-31-$38.07M-$37.96M-$29.09M
2022-12-31-$4.25M-$4.16M-$3.89M
2022-09-30-$5.11M-$5.08M-$4.93M
2022-06-30-$4.73M-$4.77M-$4.52M
2022-03-31$0.00-$4.4M-$4.55M-$3.9M
2021-12-31$0.00-$4.47M-$3.78M-$3.78M
2021-09-30-$3.57M$981,000.00$981,000.00
2021-06-30-$3.15M-$3.12M-$3.12M
2021-03-31$115,000.00-$2.3M-$5.65M
2020-12-31$81,000.00-$1.96M-$3.22M
2020-09-30-$8.03M-$6.15M
2020-06-30-$4.12M-$4.67M
2020-03-31-$4.03M$16.62M
2019-12-31-$6.15M-$12.12M
2019-09-30-$6.26M-$21.16M
2019-06-30-$8.01M-$8.85M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-03-31-$11.08M-$9.49M-$7.79M
2025-03-31-$16.68M-$12.77M-$9.57M
2024-03-31-$12.85M-$14.69M-$12.85M
2023-03-31-$52.16M-$51.97M-$42.43M
2022-03-31$0.00-$15.59M-$10.47M-$9.82M
2021-03-31$196,000.00-$16.42M-$19.68M-$19.68M
2020-03-31-$24.44M-$25.51M-$25.51M
2019-03-31-$34.41M-$39.37M-$39.37M